Bessemer Investors, a New York-based investment firm, has completed a significant investment in Xanitos Inc., a provider of environmental and support services to hospitals and ambulatory care facilities across the U.S.
The deal involves a partnership with Xanitos’ existing leadership team, including CEO Dave Crothall, who will remain in his role. Founded in 2008, Xanitos delivers a suite of healthcare support services, including environmental services, patient transport and patient observation. The company’s proprietary offerings include its patented XRO System and XanApps, an AI-powered software suite designed to improve service quality and operational efficiency. With a workforce of over 3,700 employees, Xanitos supports health systems nationwide in minimizing healthcare-associated infections and enhancing patient outcomes.
In this transaction, Solomon Partners acted as financial advisor and Simpson Thacher & Bartlett LLP as legal counsel to Xanitos. KeyBanc Capital Markets advised Bessemer on financial and capital markets matters, with legal counsel from Sidley Austin. Debt financing was provided by MidCap Financial and Stellus Capital Management.